Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 4.97M P/E - EPS this Y - Ern Qtrly Grth -
Income -3.82M Forward P/E -1.03 EPS next Y - 50D Avg Chg 32.00%
Sales 827.41k PEG - EPS past 5Y - 200D Avg Chg 21.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -50.00%
Recommedations - Quick Ratio 0.15 Shares Outstanding 121.27M 52W Low Chg 86.00%
Insider Own 0.06% ROA -244.22% Shares Float 106.83M Beta 0.98
Inst Own 11.84% ROE - Shares Shorted/Prior -/- Price 0.04
Gross Margin 100.00% Profit Margin - Avg. Volume 203,546 Target Price -
Oper. Margin -1,039.88% Earnings Date Nov 11 Volume 19,784 Change -2.38%
About APPILI THERAPEUTICS INC

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of the antibiotic metronidazole to treat anaerobic bacterial, protozoal, and parasitic infections; ATI-1801, a novel topical formulation of paromomycin in Phase III clinical trials for the treatment of cutaneous leishmaniasis and disfiguring skin infections; and ATI-1701, which is a live-attenuated vaccine in preclinical trials for Francisella tularensis. The company was incorporated in 2015 and is headquartered in Halifax, Canada.

APPILI THERAPEUTICS INC News
11/14/24 Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
11/08/24 Aditxt Provides Update on Equity Line of Credit, ATM Usage, and Outstanding Number of Shares
11/07/24 Aditxt’s Target Acquisition Appili Therapeutics Announces Results of Special Meeting of Shareholders
11/06/24 Appili Therapeutics Announces Results of Special Meeting of Shareholders
11/06/24 Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger with Aditxt's Subsidiary Adifem
10/31/24 Aditxt’s Target Acquisition Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
10/31/24 Appili Therapeutics Announces "Alignment" with FDA on ATI-1801 Development Requirements
10/31/24 Appili Therapeutics Announces Alignment with FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
10/30/24 Aditxt To Host Virtual Stakeholder Update and Q&A Session on Friday, November 1, 2024, at 11:30 AM Eastern Time
10/29/24 Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership with Broader Perspectives
10/28/24 Aditxt Completes Final Equity Investment and Key Milestone Under the Amended and Restated Merger Agreement with Evofem
10/17/24 Appili Therapeutics Presents Update on ATI-1701 Biodefense Vaccine Candidate at IDWeek™ 2024
10/10/24 Appili Therapeutics – Press Release Correction
10/10/24 Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval
10/10/24 Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders
10/03/24 Aditxt Delivers Shareholder Update and 2024 Year-End Plan
09/17/24 Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
08/29/24 Aditxt to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 9th-11th, 2024
08/21/24 Nasdaq's Aditxt Announcing Third Amendment to Arrangement Agreement with Appili Therapeutics
08/21/24 Aditxt Announces Third Amendment to Arrangement Agreement with Appili Therapeutics
APLIF Chatroom

User Image ThomasJerryLLC Posted - 4 days ago

$APLIF https://www.infrontanalytics.com/fe-en/CA03783R1073/Appili-Therapeutics-Inc-/gprv-profitability

User Image ThomasJerryLLC Posted - 4 days ago

$APLIF Earnings report today “Overwhelming shareholder support in favour of take-private transaction with Aditxt Studies presented at IDWeek 2024™ demonstrate ATI-1701 provides full protection against lethal tularemia in animal models after one year Alignment with U.S. Food and Drug Administration on development requirements for ATI-1801 NDA Submission” Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 - Appili Therapeutics https://appilitherapeutics.com/2024/11/14/appili-therapeutics-reports-financial-and-operational-results-for-second-quarter-of-fiscal-year-2025/

User Image RKitty Posted - 4 days ago

$ADTX $ADTX =💩 $EVFM =💩 $APLIF =💩 💩+💩+💩= MEGA💩

User Image Crypt0 Posted - 4 days ago

@achalm15 One might think 100% in a month for $APLIF would be worth it but I guess thats too long for people to wait.

User Image achalm15 Posted - 4 days ago

$ADTX odd how this $evfm and $APLIF are all frozen atm

User Image RKitty Posted - 4 days ago

$ADTX ALL LIES & DISTRACTIONS! I’m a 💩stock but look at the shiny $EVFM Buy me I’m 💩stock that keeps on falling but look at the shiny $APLIF

User Image Crypt0 Posted - 4 days ago

$APLIF Reported and cash rose from .1M to .7M. Stated " Subject to satisfaction or waiver of the remaining closing conditions, Appili expects the Transaction to close in December 2024 " $ADTX

User Image AlGo88 Posted - 5 days ago

$APLIF 99% profit from here

User Image Crypt0 Posted - 6 days ago

@ThomasJerryLLC @AlGo88 This is where im confused although $APLIF has done limited dilution which is good for shareholders they have done nothing to pump their stock. Just hard to read but id say deal is more than likely and if not I think they are worth 10x the price without

User Image Crypt0 Posted - 1 week ago

$ADTX Down over 99% in three months. If you have any firepowder left put on a bid for $APLIF for .03 and pray it gets picked up and get over 50% cash and this stock for FREE if the deal goes through

User Image AlGo88 Posted - 1 week ago

$APLIF interesting that the share price doesn’t reflect the shareholders approval for the acquisition, would think it would be higher or near $0.0467 (the purchase price).

User Image AlGo88 Posted - 1 week ago

$APLIF https://appilitherapeutics.com/2024/11/06/appili-therapeutics-announces-results-of-special-meeting-of-shareholders/ payday before EOY

User Image Crypt0 Posted - 1 week ago

@NBI @wwmeb You were right $APLIF is " at least 20 million ". It's a condition in the approved vote yesterday

User Image AlGo88 Posted - 1 week ago

$APLIF was it approved?

User Image Crypt0 Posted - 1 week ago

$APLIF https://event.choruscall.com/mediaframe/webcast.html?webcastid=0OG2h9L9 Its a done deal $ADTX ... Now do you want to chase the dilution or get 50% on your investment? That is assuming they get the funding, and seeing how they pillaged investors I think they have it. But you never know

User Image AlGo88 Posted - 2 weeks ago

$APLIF 2 days till pay day?

User Image Crypt0 Posted - 10/31/24

$APLIF Did anyone receive anything to vote on this buyout? $ADXT

User Image Crypt0 Posted - 10/31/24

$APLIF https://finance.yahoo.com/news/aditxt-target-acquisition-appili-therapeutics-123000557.html $ADTX Yet we aren't moving? Getting tired of this manipulation. 5.7 Million shares now thinking about voting against the buyout

User Image Crypt0 Posted - 10/25/24

$ADTX If you truly believe in this company ( which is down over 98% in 3 months ) then why wouldn't you buy $APLIF which they are buying for .0467 cash and some of this stock? Deal to be voted on in a few weeks.

User Image Crypt0 Posted - 10/22/24

$ADTX $APLIF

User Image Crypt0 Posted - 1 month ago

$APLIF Something I don't understand is money spent ( deductible ) in research is transferable in Canada. This use to be on their website. They have over 100M so if tax rate is 25% The company is worth 5X alone. This is straight corruption being sold so low $ADTX

User Image Montpbm Posted - 1 month ago

$ADTX $APLIF $CETX $STAF $PIXY

User Image Crypt0 Posted - 1 month ago

$ADTX https://finance.yahoo.com/news/appili-therapeutics-presents-ati-1701-111500308.html beating down the price to steal $APLIF

User Image RKitty Posted - 1 month ago

$ADTX One of the merger Appili $APLIF has raised $100M CAD which is around $70-73M USD. That’s pretty significant.

User Image AlGo88 Posted - 1 month ago

$APLIF new to this stock, from what I read, if the shareholders approve the sale on November 6, we get $0.0467? Seems like an easy investment to double $

User Image Crypt0 Posted - 1 month ago

@ThomasJerryLLC Are you in $APLIF or $ADTX ?

User Image Crypt0 Posted - 1 month ago

@ThomasJerryLLC They stole $APLIF, who is voting on the buyout in a couple weeks which seems likely at this point. .0467 cash and stock and a gift to anyone who buys at the current price

User Image Crypt0 Posted - 1 month ago

@TimingTimingTiming $ADTX going to have a Q & A Friday and updates on acquisitions. Maybe we can get some clarity on $APLIF acquisition

User Image RKitty Posted - 1 month ago

$ADTX Enterprise Value (EV) = $8M $EVFM EV = $49M $APLIF EV = $9.5M Total = $66.5M $66.5M/245K shares = $271

User Image Crypt0 Posted - 1 month ago

@TimingTimingTiming I agree but my guess is $ADTX easily made enough for the acquisition of $APLIF with todays pump. I agree they did it on the backs of said "retail"